Aristopharma Ltd. began its journey in 1986 with a commitment to making quality medicines affordable for people in Bangladesh. Today, it ranks among the country’s top 10 pharmaceutical companies, operating two manufacturing plants in Dhaka and Gazipur. Its diverse product range covers numerous therapeutic categories, including antibiotics, cardiovascular medicines, diabetes treatments, and cancer therapies. The company also produces specialized products such as prefilled syringes, inhalers, and biotechnology medicines, following WHO-approved cGMP guidelines. Aristopharma started exporting medicines in 2000, with Vietnam as its first international market. It now supplies products to 30 countries across five continents. The company entered the oncology sector in 2017 and began manufacturing sterile ophthalmic products in 2002. With a strong focus on research, quality assurance, and continuous improvement, Aristopharma continues to expand its product portfolio and international presence.